Skip to main content

Advertisement

Table 5 Odds ratios (OR) and 95% confidence (CIs) intervals for case–control associations with BMI, education and annual income for early and advanced stage ovarian cancer, the African American Cancer Epidemiology Study (AACES), 2010-14†

From: A multi-center population-based case–control study of ovarian cancer in African-American women: the African American Cancer Epidemiology Study (AACES)

  Early Stage at Diagnosis (Stage I/II) Advanced Stage at Diagnosis (Stage III/IV)
Variable Controls (N = 622) Cases (N = 168)      Cases (N = 182)     
  N (%) N (%) OR* (95% CI) OR** (95% CI) N (%) OR* (95% CI) OR** (95% CI)
Body mass index 1 year before diagnosis (kg/m 2 )            
<24.9 119 (19.2) 25 (14.9) 1.00 Referent 1.00 Referent 26 (14.4) 1.00 Referent 1.00 Referent
25–29.9 157 (25.3) 38 (22.6) 1.10 (0.63-1.93) 1.18 (0.66-2.08) 50 (27.6) 1.33 (0.77-2.27) 1.31 (0.76-2.26)
30–34.9 157 (25.3) 51 (30.4) 1.53 (0.90-2.62) 1.56 (0.90-2.68) 51 (28.2) 1.46 (0.85-2.49) 1.45 (0.84-2.48)
> = 35 188 (30.3) 54 (32.1) 1.33 (0.78-2.26) 1.33 (0.78-2.28) 54 (29.8) 1.31 (0.77-2.22) 1.23 (0.72-2.09)
Missing 1       1     
Education            
High school or less 223 (35.9) 80 (47.6) 1.00 Referent 1.00 Referent 84 (46.2) 1.00 Referent 1.00 Referent
Some post-high school training 227 (36.6) 47 (28.0) 0.60 (0.40-0.89) 0.59 (0.39-0.90) 62 (34.1) 0.78 (0.53-1.14) 0.84 (0.56-1.25)
College or graduate degree 171 (27.5) 41 (24.4) 0.69 (0.45-1.06) 0.65 (0.41-1.04) 36 (19.8) 0.59 (0.38-0.93) 0.67 (0.42-1.09)
Missing 1           
Annual Income            
< $10,000 130 (21.2) 43 (25.9) 1.00 Referent 1.00 Referent 37 (20.8) 1.00 Referent 1.00 Referent
$10,000 - < $25,000 145 (23.6) 41 (24.7) 0.85 (0.52-1.39) 0.86 (0.52-1.43) 49 (27.5) 1.15 (0.70-1.89) 1.19 (0.72-1.96)
$25,000 - < $50,000 131 (21.3) 41 (24.7) 0.96 (0.59-1.58) 0.96 (0.58-1.60) 43 (24.2) 1.17 (0.70-1.94) 1.27 (0.75-2.13)
$50,000 - < $75.000 103 (16.8) 23 (13.9) 0.68 (0.38-1.20) 0.69 (0.38-1.25) 23 (12.9) 0.79 (0.44-1.42) 0.91 (0.49-1.67)
≥ $75,000 105 (17.1) 18 (10.8) 0.52 (0.28-0.96) 0.54 (0.29-1.02) 26 (14.6) 0.90 (0.51-1.59) 1.09 (0.60-1.99)
Missing 8 2      4     
  1. †Seventeen controls were excluded from this table; 14 cases excluded from the early stage cases and 17 cases excluded from advanced stage cases due to missing data for either parity or months of oral contraceptive use.
  2. *Age adjusted(ORs).
  3. **Multivariable adjusted (ORs) adjusted for age, months of oral contraceptive use, and parity.